CAS 159013-54-4
:BIBP 3226
Description:
BIBP 3226, with the CAS number 159013-54-4, is a selective antagonist of the neuropeptide Y (NPY) Y1 receptor. This compound is primarily utilized in research settings to investigate the physiological roles of NPY and its receptors, particularly in the context of appetite regulation, anxiety, and cardiovascular functions. BIBP 3226 exhibits high affinity for the Y1 receptor, making it a valuable tool for studying the receptor's signaling pathways and potential therapeutic applications. The compound is typically characterized by its ability to inhibit NPY-induced responses, thus providing insights into the mechanisms of NPY-related processes. In terms of its chemical structure, BIBP 3226 features specific functional groups that contribute to its receptor-binding properties. As with many research chemicals, safety and handling precautions are essential, as the compound may have specific toxicity profiles or require careful storage conditions. Overall, BIBP 3226 serves as an important compound in neuropharmacological research, aiding in the understanding of neuropeptide signaling.
Formula:C27H31N5O3
InChI:InChI=1S/C27H31N5O3/c28-27(29)30-17-7-12-23(25(34)31-18-19-13-15-22(33)16-14-19)32-26(35)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-6,8-11,13-16,23-24,33H,7,12,17-18H2,(H,31,34)(H,32,35)(H4,28,29,30)/t23-/m1/s1
InChI key:InChIKey=KUWBXRGRMQZCSS-HSZRJFAPSA-N
SMILES:C(C(N[C@@H](C(NCC1=CC=C(O)C=C1)=O)CCCNC(=N)N)=O)(C2=CC=CC=C2)C3=CC=CC=C3
Synonyms:- (2R)-5-(Diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide
- Benzeneacetamide,N-[4-[(aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-a-phenyl-, (R)-
- Bibp 3226
- N-[(1R)-4-[(Aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-α-phenylbenzeneacetamide
- Benzeneacetamide, N-[(1R)-4-[(aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-α-phenyl-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
BIBP3226
CAS:The Y₁ receptor antagonist BIBP-3226, a derivative of D-arginine, binds to the Y₁ receptor with high affinity (its Ki was 7 nM versus the Ki of 0.2 nM for NPY). BIBP3226 also reduced the NPY-induced increase in intracellular calcium as well as the pressor response in vitro and in vivo. BIBP3226 inhibited NPY induced feeding in rats. In dogs, intra-arterial infusion of BIBP-3226 interrupted tonic NPY Y1 receptor-mediated vasoconstriction in exercising skeletal muscle, resulting in substantial increases in experimental limb blood flow. CAS-Number (trifluoroacetate): 1068148-47-9.Formula:C27H31N5O3Purity:98.8%Color and Shape:White PowderMolecular weight:473.58BIBP 3226 trifluoroacetate
CAS:Formula:C27H31N5O3·CF3CO2HPurity:≥ 98.0% (HPLC)Color and Shape:White solid or powderMolecular weight:587.59BIBP3226
CAS:<p>BIBP3226 is a potent and selective antagonist for the Neuropeptide Y receptor Y1 and the neuropeptide FF receptor.</p>Formula:C27H31N5O3Color and Shape:SolidMolecular weight:473.57BIBP 3226
CAS:<p>BIBP 3226 is a drug that belongs to the class of beta-blockers. It is a potent and selective beta-adrenergic receptor antagonist that has been shown to have maximal response in the concentration range of 1 nM to 10 micromolar. The effects on blood pressure are dose dependent, with a maximal effect at doses greater than or equal to 0.1 mg/kg. BIBP 3226 has been found to inhibit insulin resistance and increase cardiac contractility in rats, and may also have an inhibitory effect on platelet aggregation. This drug exhibits pharmacokinetic properties that are independent of food intake and is metabolized by CYP3A4 in the liver.</p>Formula:C29H32F3N5O5Purity:Min. 95%Molecular weight:587.6 g/mol



